Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 3 EP applications Jenna Marie Ahern has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after February 17, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14732852

RETOSIBAN FOR THE TREATMENT OF PRE-TERM LABOUR

IPC classification:
A61K 31/5377, A61P 5/24
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Jenna Marie Ahern, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP16706002

4 -SUBSTITUTED BENZOXABOROLE COMPOUNDS AND USES THEREOF

IPC classification:
A61K 31/69, A61P 31/06, C07F 5/02
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Jenna Marie Ahern, GlaxoSmithKline
Status:
Request for examination was made
EP16706003

BENZOXABOROLE COMPOUNDS AND USES THEREOF

IPC classification:
A61K 31/69, A61P 31/06, C07F 5/02
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Jenna Marie Ahern, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature